Humana Inc. (NYSE: HUM) has reported earnings for its second fiscal quarter (ending June 30) of $5.63 versus $7.70 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $14.08 versus $26.95 for the same period a year ago.
Recent Price Action
On 7/31/24, Humana Inc. (NYSE: HUM) stock suffered a major decline of -10.6%, closing at $361.61. Moreover, exceptionally high trading volume at 320% of normal accompanied the decline. The stock has been extremely weak relative to the market over the last nine months and has declined -6.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, HUM is expected to continue to be a Value Builder.
Humana has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Humana has a neutral Appreciation Score of 45 but a very low Power Rating of 2, triggering the Lowest Value Trend Rating.
Rating Review
In light of this new information and highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment